Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure

Hematopoietic cell transplantation (HCT) is the only readily available cure for many life-threatening pediatric nonmalignant diseases (NMD), but most patients lack a matched related donor and are at higher risk for graft-versus-host disease (GVHD). Use of abatacept (Aba) to target donor T-cell activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenger, Elizabeth O., Watkins, Benjamin, Rogowski, Kelsey, Chiang, Kuang-Yueh, Haight, Ann, Leung, Kathryn, Qayed, Muna, Raghunandan, Sharmila, Suessmuth, Yvonne, Kean, Leslie, Horan, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196963/
https://www.ncbi.nlm.nih.gov/pubmed/36724508
http://dx.doi.org/10.1182/bloodadvances.2022008545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196963/
https://www.ncbi.nlm.nih.gov/pubmed/36724508
http://dx.doi.org/10.1182/bloodadvances.2022008545

Ejemplares similares